JP2024500360A5 - - Google Patents
Info
- Publication number
- JP2024500360A5 JP2024500360A5 JP2023535468A JP2023535468A JP2024500360A5 JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5 JP 2023535468 A JP2023535468 A JP 2023535468A JP 2023535468 A JP2023535468 A JP 2023535468A JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- polymerosomes
- seq
- peo
- populations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20213488 | 2020-12-11 | ||
| EP20213488.8 | 2020-12-11 | ||
| PCT/EP2021/085366 WO2022123070A1 (en) | 2020-12-11 | 2021-12-13 | Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500360A JP2024500360A (ja) | 2024-01-09 |
| JP2024500360A5 true JP2024500360A5 (cg-RX-API-DMAC10.html) | 2024-07-11 |
Family
ID=74187071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535468A Pending JP2024500360A (ja) | 2020-12-11 | 2021-12-13 | 関連づけられた抗原および関連づけられたアジュバントを有する2つのポリマーソーム集団を投与することによる、Th1/Th2免疫応答の調整方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230398207A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4259197A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024500360A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021396659A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3193643A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022123070A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111450060A (zh) * | 2012-11-19 | 2020-07-28 | 新加坡科技研究局 | 用于引发对免疫原的免疫响应的方法 |
| WO2024086380A2 (en) * | 2022-10-21 | 2024-04-25 | Pds Biotechnology Corporation | Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5354934A (en) | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| WO2009127537A1 (en) | 2008-04-17 | 2009-10-22 | GÜNZBURG, Walter | Post release modification of viral envelopes |
| US8323696B2 (en) | 2008-08-29 | 2012-12-04 | Ecole Polytechnique Federale De Lausanne | Nanoparticles for immunotherapy |
| US10364350B2 (en) | 2009-04-20 | 2019-07-30 | Agency For Science, Technology And Research | Vesicular system and uses thereof |
| WO2012018306A1 (en) | 2010-08-05 | 2012-02-09 | Agency For Science, Technology And Research | A multicompartmentalized vesicular structure and a method for forming the same |
| CA3170184A1 (en) | 2012-03-12 | 2013-09-19 | Advanced Bioadjuvants, Llc | Adjuvant and vaccine compositions |
| US20150233800A1 (en) | 2012-10-11 | 2015-08-20 | Vin-De-Bona Trading Company Pte Ltd | Method of painting microvesicles |
| CN111450060A (zh) | 2012-11-19 | 2020-07-28 | 新加坡科技研究局 | 用于引发对免疫原的免疫响应的方法 |
| KR20200039025A (ko) * | 2013-09-19 | 2020-04-14 | 조에티스 서비시즈 엘엘씨 | 유성 아쥬반트 |
| EP2898894A1 (en) | 2014-01-27 | 2015-07-29 | LTS LOHMANN Therapie-Systeme AG | Nano-in-micro particles for intradermal delivery |
| WO2016154432A1 (en) | 2015-03-24 | 2016-09-29 | VaxLiant, LLC | Adjuvant compositions and related methods |
| US10696985B1 (en) * | 2016-06-06 | 2020-06-30 | Vanderbilt University | Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery |
| JP7542257B2 (ja) * | 2018-01-25 | 2024-08-30 | エイシーエム バイオラブズ プライベート リミテッド | 可溶化された封入抗原を含むポリマーソーム、ならびにその作製および使用方法 |
| CA3143533A1 (en) * | 2019-08-01 | 2021-02-04 | Madhavan Nallani | A method of eliciting an immune response by administering a population of polymersomes having an associated antigen together with a population of polymersomes having an associated adjuvant as well as compositions comprising the two populations of polymersome |
| WO2021214339A2 (en) * | 2020-04-24 | 2021-10-28 | Acm Biolabs Pte Ltd | Vaccine against human-pathogenic coronaviruses |
-
2021
- 2021-12-13 EP EP21836471.9A patent/EP4259197A1/en active Pending
- 2021-12-13 US US18/256,896 patent/US20230398207A1/en active Pending
- 2021-12-13 JP JP2023535468A patent/JP2024500360A/ja active Pending
- 2021-12-13 CA CA3193643A patent/CA3193643A1/en active Pending
- 2021-12-13 WO PCT/EP2021/085366 patent/WO2022123070A1/en not_active Ceased
- 2021-12-13 AU AU2021396659A patent/AU2021396659A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543038A5 (cg-RX-API-DMAC10.html) | ||
| US20080124350A1 (en) | Nanoparticle-based vaccine delivery system containing adjuvant | |
| US6359054B1 (en) | Polynucleotide compositions for intramuscular administration | |
| CN114728154A (zh) | 基于丝素蛋白的微针及其用途 | |
| Yang et al. | Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori | |
| TR201904758T4 (tr) | İmmünoterapiye yönelik RNA formülasyonu. | |
| JP2021512142A5 (cg-RX-API-DMAC10.html) | ||
| CN112118847A (zh) | 包含突变kras序列和脂质的化合物及其用途 | |
| US9750692B2 (en) | Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant | |
| US7256180B2 (en) | Compositions and methods for inducing activation of dendritic cells | |
| Hassan et al. | From antigen uptake to immune modulation: The multifaceted potential of peptide nanofibers as vaccine nanocarriers | |
| US20250235532A1 (en) | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof | |
| CN118055775A (zh) | 包括hsp90抗原肽的抗癌用疫苗组合物及其用途 | |
| Singh et al. | Applications of nanotechnology in vaccine delivery | |
| US20240181070A1 (en) | Nanovaccines for treatment of viral diseases | |
| WO2001083698A2 (en) | Compositions and methods for inducing activation of dendritic cells | |
| CN120769913A (zh) | 基于核酸的癌症疫苗及其方法 | |
| US20220370488A1 (en) | Mucus penetrating particle compositions and methods of use thereof enhancing immune response | |
| JP2024505964A5 (cg-RX-API-DMAC10.html) | ||
| TW202108169A (zh) | 裝載抗原決定位與佐劑之奈米粒子之疫苗、其製備方法及中和病毒感染方法 | |
| KR102901149B1 (ko) | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 | |
| WO2024186646A1 (en) | Methods of making lipid adjuvanted compositions | |
| Khan et al. | Nanovaccines against viral infections: Current trends and future prospects | |
| Misra et al. | Vaccine Design, Nanoparticle Vaccines and Biomaterial Applications | |
| Votaw | Polysequence Nanomaterials for Immunomodulation |